Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Select Medical Holdings (SEM) Short-term Investments (2022 - 2024)

Historic Short-term Investments for Select Medical Holdings (SEM) over the last 3 years, with Q2 2024 value amounting to $22.4 million.

  • Select Medical Holdings' Short-term Investments fell 7328.27% to $22.4 million in Q2 2024 from the same period last year, while for Jun 2024 it was $22.4 million, marking a year-over-year decrease of 7328.27%. This contributed to the annual value of $59.0 million for FY2023, which is 2123.38% down from last year.
  • Latest data reveals that Select Medical Holdings reported Short-term Investments of $22.4 million as of Q2 2024, which was down 7328.27% from $42.7 million recorded in Q1 2024.
  • Select Medical Holdings' Short-term Investments' 5-year high stood at $85.9 million during Q3 2023, with a 5-year trough of $22.4 million in Q2 2024.
  • Over the past 3 years, Select Medical Holdings' median Short-term Investments value was $72.1 million (recorded in 2023), while the average stood at $63.0 million.
  • Its Short-term Investments has fluctuated over the past 5 years, first tumbled by 2123.38% in 2023, then plummeted by 7328.27% in 2024.
  • Quarter analysis of 3 years shows Select Medical Holdings' Short-term Investments stood at $74.9 million in 2022, then fell by 21.23% to $59.0 million in 2023, then crashed by 61.97% to $22.4 million in 2024.
  • Its last three reported values are $22.4 million in Q2 2024, $42.7 million for Q1 2024, and $59.0 million during Q4 2023.